Correlation Between Cigna Corp and Nexalin Technology

Can any of the company-specific risk be diversified away by investing in both Cigna Corp and Nexalin Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cigna Corp and Nexalin Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cigna Corp and Nexalin Technology, you can compare the effects of market volatilities on Cigna Corp and Nexalin Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cigna Corp with a short position of Nexalin Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cigna Corp and Nexalin Technology.

Diversification Opportunities for Cigna Corp and Nexalin Technology

-0.5

Correlation Coefficient

Cigna Corp  Nexalin Technology

Very good diversification

The 3 months correlation between Cigna and Nexalin is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Cigna Corp and Nexalin Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexalin Technology and Cigna Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cigna Corp are associated (or correlated) with Nexalin Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexalin Technology has no effect on the direction of Cigna Corp i.e., Cigna Corp and Nexalin Technology go up and down completely randomly.

Pair Corralation between Cigna Corp and Nexalin Technology

Allowing for the 90-day total investment horizon Cigna Corp is expected to generate 36.95 times less return on investment than Nexalin Technology. But when comparing it to its historical volatility, Cigna Corp is 8.48 times less risky than Nexalin Technology. It trades about 0.02 of its potential returns per unit of risk. Nexalin Technology is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  44.00  in Nexalin Technology on September 28, 2024 and sell it today you would earn a total of  229.00  from holding Nexalin Technology or generate 520.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	99.63%
Values	Daily Returns

Cigna Corp  vs.  Nexalin Technology

Cigna Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cigna Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Nexalin Technology

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Nexalin Technology are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent basic indicators, Nexalin Technology disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cigna Corp and Nexalin Technology

The main advantage of trading using opposite Cigna Corp and Nexalin Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cigna Corp position performs unexpectedly, Nexalin Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexalin Technology will offset losses from the drop in Nexalin Technology's long position.

The idea behind Cigna Corp and Nexalin Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.